Suchergebnisse - "KE CHANGWEN"

PubPharm (9)

1

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants

enthalten in: Nature communications | 2023

von Yu, H. | Liu, B. | Zhang, Y. | +36

2

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Li, Y. | He, J. | Zhang, Y. | +9

3

Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants

enthalten in: Virology journal | 2022

von Liao, G. | Lau, H. | Liu, Z. | +32

4

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection

enthalten in: Emerging microbes & infections | 2022

von Liang, H. | Zheng, P. | Wang, Q. | +16

5

A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates

enthalten in: Emerging microbes & infections | 2022

von An, Y. | Li, S. | Jin, X. | +25

6

Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Chen, R. | Zhang, X. | Yuan, Y. | +26

7

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route

enthalten in: Signal transduction and targeted therapy | 2021

von Pan, T. | Chen, R. | He, X. | +13

8

Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates

enthalten in: ACS nano | 2021

von Kang, Y. | Sun, C. | Zhuang, Z. | +18

9

Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

enthalten in: Journal of virology | 2020

von Liu, Z. | Zheng, H. | Lin, H. | +18

1
[1]